CRIPTO3 and neoplasm: Therefore, although tumor cells could be coated with iC3b molecules, the binding of iC3b to CD18 subunit of CR3 on leukocytes is not sufficient to induce the leukocyte to kill the target (tumor cells) due to a lack of β-glucan-binding to CD11b on leukocytes (Figure 2B).